Gatiflox ES Sterile Eye Drops: Each ml contains Gatifloxacin Sesquihydrate INN equivalent to Gatifloxacin 5 mg.
Gatiflox ES is an 8-methoxyfluoroquinolone anti-infective for the treatment of bacterial conjunctivitis. The antibacterial action of Gatifloxacin results from inhibition of DNA gyrase and topoisomerase IV. DNA gyrase is an essential enzyme that is involved in the replication, transcription and repair of bacterial DNA. Topoisomerase IV is an enzyme known to play a key role in the partitioning of the chromosomal DNA during bacterial cell division. It appears that the C-8-methoxy moiety contributes to enhanced activity and lower selection of resistant mutants of gram-positive bacteria compared to the nonmethoxy C-8 moiety.
Gatiflox ES is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms:
Aerobic Gram-Positive Bacteria:
Aerobic Gram-Negative Bacteria:
Patients 1 year of age or older: Instill one drop every two hours in the affected eye(s) while awake, up to 8 times on Day 1. Instill one drop two to four times daily in the affected eye(s) while awake on Days 2 through 7.
Most common adverse reactions were eye irritation, dysgeusia, increased lacrimation and eye pain.
Patients should not wear contact lenses if they have signs or symptoms of bacterial conjunctivitis or during the course of therapy with this eye drops.
As with other anti-infectives, prolonged use of this eye drops may result in overgrowth of nonsusceptible organisms, including fungi. If superinfection occurs, discontinue use and institute alternative therapy.
Pregnancy: Pregnancy Category C. There are no adequate and well-controlled studies in pregnant women; it should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.
Lactation: It is not known whether it is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when Gatiflox® ES is administered to a lactating woman.